Mitchell Jones - May 28, 2024 Form 4 Insider Report for PALISADE BIO, INC. (PALI)

Role
Chief Medical Officer
Signature
/s/ Mitchell Jones
Stock symbol
PALI
Transactions as of
May 28, 2024
Transactions value $
-$6,050
Form type
4
Date filed
5/30/2024, 07:44 PM
Previous filing
May 8, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PALI Common Stock, par value $0.01 Options Exercise $0 +2.74K +328.33% $0.00 3.57K May 28, 2024 Direct F1
transaction PALI Common Stock, par value $0.01 Tax liability -$3.86K -810 -22.7% $4.76 2.76K May 28, 2024 Direct F2
transaction PALI Common Stock, par value $0.01 Options Exercise $0 +1.56K +56.38% $0.00 4.31K May 28, 2024 Direct F3
transaction PALI Common Stock, par value $0.01 Tax liability -$2.19K -461 -10.69% $4.76 3.85K May 28, 2024 Direct F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PALI Restricted Stock Units Options Exercise -2.74K -100% 0 May 28, 2024 Common Stock 2.74K Direct F5, F6
transaction PALI Restricted Stock Units Options Exercise -1.56K -100% 0 May 28, 2024 Common Stock 1.56K Direct F5, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on September 5, 2023.
F2 Represents shares withheld to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units referenced in footnote 1.
F3 Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on November 21, 2023.
F4 Represents shares withheld to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units referenced in footnote 3.
F5 Each restricted stock unit represents the right to receive, at settlement, one share of common stock.
F6 This restricted stock unit was granted on September 5, 2023, and all remaining 2,735 restricted stock units subject to the award were accelerated and vested on May 28, 2024 by the Compensation Committee of the Issuer.
F7 This restricted stock unit was granted on November 21 2024, and all remaining 1,555 restricted stock units subject to the award were accelerated and vested on May 28, 2024 by the Compensation Committee of the Issuer.